Cutting Edge Spine gains clearance for HA-enhanced PEEK interbody system

Cutting Edge Spine launched the EVOLha-DLIF direct lateral interbody fusion system on Jan. 9 following FDA 510(k) clearance.

Advertisement

Three insights:

1. EVOLha-DLIF is designed with PEEK-OPTIMA hyaluronic acid-enhanced material from Invibio Biomaterial Solutions.

2. The company’s spine implants featuring the new material have shown early onset bone formation and apposition to its implants.

3. Cutting Edge Spine has seven 510(k) cleared devices and aims to launch several more this year.

More articles on devices:
Dr. Bryan Little appointed to state medical board, task force
Former Medtronic, Bioventus executive becomes CEO at BlueWind Medical
Exactech co-founders retire, current CEO to transition to board role — 4 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.